Results 171 to 180 of about 5,314 (201)

Application of different chemometric assisted models for spectrophotometric quantitative analysis of velpatasvir and sofosbuvir

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2021
Mohammed Shahin
exaly  

Sofosbuvir/velpatasvir

Reactions Weekly
  +5 more sources

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2021
openaire   +2 more sources

Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial

The Lancet Gastroenterology and Hepatology, 2022
Jean Damascene Makuza, Claude Mambo Muvunyi, Jean Damascene Kabakambira   +2 more
exaly  

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

New England Journal of Medicine, 2015
Jonathan M Fenkel, K Rajender Reddy, Eric Lawitz   +2 more
exaly  

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2021
openaire   +2 more sources

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2022
openaire   +2 more sources

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

New England Journal of Medicine, 2017
Myron Tong, Hadas Dvory-Sobol, Philippe Mathurin   +2 more
exaly  

Sofosbuvir and Velpatasvir for Patients with HCV Infection

New England Journal of Medicine, 2016
Graham R Foster, Alessandra Mangia
exaly  

Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

The Lancet Gastroenterology and Hepatology, 2019
Lai Wei, Seng Gee Lim, Qing Xie
exaly